N-aryl heterocycles via coupling reactions with arylboronic acids

Tetrahedron

Volumn 55, Issue 44, 1999, Pages 12757-12770

  Mederski, Werner W K R ^a   Lefort, Marina ^a   Germann, Martina ^a   Kux, Dieter ^a  

^a MERCK KGAA   (Germany)

Author keywords

Arylation; Coupling reactions; Indoles; Pyridazinones; Pyridones; Pyrroles

Indexed keywords

BLOOD CLOTTING FACTOR 10A INHIBITOR; BORONIC ACID DERIVATIVE; ESTER; HETEROCYCLIC COMPOUND; INDOLE DERIVATIVE;

ARTICLE; BLOOD CLOTTING; CHEMICAL MODIFICATION; DRUG STRUCTURE; DRUG SYNTHESIS; MASS SPECTROMETRY; NUCLEAR MAGNETIC RESONANCE; PRIORITY JOURNAL; REACTION ANALYSIS; STRUCTURE ACTIVITY RELATION;

EID: 0033615795     PISSN: 00404020     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0040-4020(99)00752-8     Document Type: Article

References (21)

1. (a) Mederski, W. W. K. R.; Dorsch, D.; Bokel, H.-H.; Beier, N.; Lues, I.; Schelling, P. J. Med. Chem. 1994, 37, 1632.
2. (b) Mederski, W. W. K. R.; Dorsch, D.; Osswald, M.; Schwartz, H.; Beier, N.; Christadler, M.; Minck, K.-O.; Schelling, P.; Schmitges, C.-J. Eur. J. Med. Chem 1997, 32, 479.
3. Mederski, W. W. K. R.; Osswald, M.; Dorsch, D.; Christadler, M.; Schmitges, C.-J.; Wilm, C. Bioorg. Med. Chem. Lett. 1999, 9, 619.
4. (a) Osswald, M.; Mederski, W. W. K. R.; Schwarz, M.; Beier, N.; Lues, I.; Minck, K.-O. Bioorg. Med. Chem. Lett. 1994, 4, 683.
5. (b) Koppe, T.; Mederski, W. W. K. R.; Osswald, M.; Schwarz, M. Tetrahedron. Lett. 1995, 36, 377.
6. Goldberg I. Ber. Dtsch. Chem. Ges. 1906, 39, 1691.
7. (a) Renger B. Synthesis 1985, 856.
8. (b) Sugahara M.; Ukita T. Chem. Pharm. Bull. 1997, 45, 719.
9. López-Alvarado, P.; Avendañno, C.; Menéndez, C. J. J. Chem. Soc. Perkin Trans, 1 1997, 229.
10. (a) Chan, D. T.; Monaco K. L.; Wang, R.-U.; Winters M. P. Tetrahedron. Lett. 1998, 39, 2933.
11. (b) Lam, P. Y. S.; Clark, C. G.; Saubern, S.; Adams, J., Winters, M. P.; Chan, D. M. T.; Combs, A. Tetrahedron. Lett. 1998, 39, 2941.
12. For the synthesis of 3, see: Srivastava, R. M.; Mendes e Silva, L. M. J. Chem. Eng. Data 1984, 29, 221.
13. In our case 5-methyl-1,2,4-oxadiazoles serve as protecting groups for amidines which are crucial functionalities in the field of factor Xa antagonists.
14. Wang, T.-C.; Chen, Y.-L.; Lee, K.-H.; Tzeng, C.-C. Synthesis 1997, 87.
15. For O-arylation of phenols with boronic acids and cupric acetate, compare: Evans, D. A.; Katz, J. L.; West, T. R. Tetrahedron Lett. 1998, 39, 2937.
16. For 19a, see: Yutilov Y. M.; Svertilova, I. A. Ximiya Geterotsikl. Soedin. 1982, 705.
17. For the synthesis of 22a, see: Mali, R. S.; Yadav, V. J. Synthesis 1984, 862.
18. Initial screening of various tertiary amines with 22b revealed that pyridine was the preferred base in this series. Therefore we kept this parameter constant.
19. For the synthesis of 25b, see: Sakamoto, S.; Nagano, T.; Kondo Y.; Yamanaka, H. Chem. Pharm. Bull. 1988, 36, 2248.
20. Bunker, A. M.; Edmunds, J. J.; Berryman, K. A.; Walker, D. M.; Flynn, M. A.; Welch, K. M.; Doherty, A. M. Bioorg. Med. Chem. Lett. 1996, 6, 1061.
21. For the synthesis and spectroscopical characterization of 8a, see: Sugahara, M.; Ukita, T. Chem. Pharm. Bull. 1997, 45, 719.